| 1 | HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction | 8.5 | 3 | Citations (PDF) |
| 2 | <scp>USP3</scp>: Key deubiquitylation enzyme in human diseases | 4.0 | 0 | Citations (PDF) |
| 3 | IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer | 0.6 | 6 | Citations (PDF) |
| 4 | CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer | 6.7 | 3 | Citations (PDF) |
| 5 | Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway | 11.3 | 2 | Citations (PDF) |
| 6 | PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer | 8.5 | 2 | Citations (PDF) |
| 7 | BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression | 6.6 | 0 | Citations (PDF) |
| 8 | Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells | 6.1 | 0 | Citations (PDF) |
| 9 | TNFAIP2 promotes HIF1α transcription and breast cancer angiogenesis by activating the Rac1-ERK-AP1 signaling axis | 8.5 | 0 | Citations (PDF) |
| 10 | Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer | 11.5 | 1 | Citations (PDF) |
| 11 | RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy | 12.8 | 22 | Citations (PDF) |
| 12 | A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer | 8.5 | 11 | Citations (PDF) |
| 13 | Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer | 8.6 | 15 | Citations (PDF) |
| 14 | Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1 | 1.6 | 3 | Citations (PDF) |
| 15 | LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2 | 4.5 | 12 | Citations (PDF) |
| 16 | Author Response: Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1 2023, , | | 0 | Citations (PDF) |
| 17 | SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1 | 2.3 | 2 | Citations (PDF) |
| 18 | Kindlin-2 in myoepithelium controls luminal progenitor commitment to alveoli in mouse mammary gland | 8.5 | 3 | Citations (PDF) |
| 19 | YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer | 13.7 | 40 | Citations (PDF) |
| 20 | Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer | 8.6 | 15 | Citations (PDF) |
| 21 | PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer | 10.5 | 74 | Citations (PDF) |
| 22 | STAMBPL1 promotes breast cancer cell resistance to cisplatin partially by stabilizing MKP-1 expression | 6.6 | 10 | Citations (PDF) |
| 23 | Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor–Stroma Cross-talk | 0.6 | 15 | Citations (PDF) |
| 24 | YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy | 4.8 | 28 | Citations (PDF) |
| 25 | A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer | 8.5 | 6 | Citations (PDF) |
| 26 | Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis | 26.3 | 19 | Citations (PDF) |
| 27 | Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells | 4.8 | 3 | Citations (PDF) |
| 28 | METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions | 14.1 | 43 | Citations (PDF) |
| 29 | Progress of Breast Cancer basic research in China | 8.6 | 60 | Citations (PDF) |
| 30 | Isochromanoindolenines suppress triple-negative breast cancer cell proliferation partially via inhibiting Akt activation | 8.6 | 3 | Citations (PDF) |
| 31 | Glucose-6-phosphate dehydrogenase neutralizes stresses by supporting reductive glutamine metabolism and AMPK activation | 26.3 | 10 | Citations (PDF) |
| 32 | Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer | 4.0 | 218 | Citations (PDF) |
| 33 | EphA2: A promising therapeutic target in breast cancer | 4.4 | 36 | Citations (PDF) |
| 34 | Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib | 8.5 | 18 | Citations (PDF) |
| 35 | Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor | 14.1 | 37 | Citations (PDF) |
| 36 | The roles and regulation of the KLF5 transcription factor in cancers | 4.0 | 81 | Citations (PDF) |
| 37 | Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS | 26.3 | 33 | Citations (PDF) |
| 38 | Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer | 13.7 | 34 | Citations (PDF) |
| 39 | Characterization of tree shrew telomeres and telomerase | 4.4 | 2 | Citations (PDF) |
| 40 | The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China | 2.5 | 4 | Citations (PDF) |
| 41 | KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer | 12.8 | 45 | Citations (PDF) |
| 42 | Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia | 11.6 | 74 | Citations (PDF) |
| 43 | KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1 | 8.5 | 21 | Citations (PDF) |
| 44 | Cancer progression is mediated by proline catabolism in non-small cell lung cancer | 6.6 | 53 | Citations (PDF) |
| 45 | Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer | 4.0 | 49 | Citations (PDF) |
| 46 | Inhibiting both proline biosynthesis and lipogenesis synergistically suppresses tumor growth | 8.1 | 37 | Citations (PDF) |
| 47 | A functional missense variant in ITIH3 affects protein expression and neurodevelopment and confers schizophrenia risk in the Han Chinese population | 4.4 | 11 | Citations (PDF) |
| 48 | SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFR | 12.8 | 47 | Citations (PDF) |
| 49 | Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy | 9.0 | 16 | Citations (PDF) |
| 50 | TNF-α increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-κB pathway | 3.7 | 65 | Citations (PDF) |
| 51 | Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis | 8.6 | 14 | Citations (PDF) |
| 52 | A new Schiff base copper(II) complex induces cancer cell growth inhibition and apoptosis by multiple mechanisms | 3.0 | 22 | Citations (PDF) |
| 53 | Pyrrolo [3,4-b]-quinolin-9-amine compound FZU-0038-056 suppresses triple-negative breast cancer partially through inhibiting the expression of Bcl-2Aging, 2020, 12, 9621-9632 | 2.5 | 3 | Citations (PDF) |
| 54 | Heterogeneity and Subtyping of Triple-Negative Breast Cancer 2020, , 21-40 | | 0 | Citations (PDF) |
| 55 | Comprehensive analysis of long noncoding RNAs and mRNAs expression profiles and functional networks during chondrogenic differentiation of murine ATDC5 cells | 2.0 | 2 | Citations (PDF) |
| 56 | Glucocorticoid Receptor Signaling Activates TEAD4 to Promote Breast Cancer Progression | 0.6 | 78 | Citations (PDF) |
| 57 | Ilamycin E, a natural product of marine actinomycete, inhibits triple-negative breast cancer partially through ER stress-CHOP-Bcl-2 | 8.6 | 43 | Citations (PDF) |
| 58 | Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers | 8.6 | 35 | Citations (PDF) |
| 59 | USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5 | 2.3 | 53 | Citations (PDF) |
| 60 | A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3 | 2.3 | 22 | Citations (PDF) |
| 61 | Tumor Suppression of Ras GTPase-Activating Protein RASA5 through Antagonizing Ras Signaling Perturbation in Carcinomas | 3.8 | 11 | Citations (PDF) |
| 62 | HDAC inhibitors induce proline dehydrogenase (POX) transcription and anti-apoptotic autophagy in triple negative breast cancer | 2.0 | 21 | Citations (PDF) |
| 63 | Genetic basis of ruminant headgear and rapid antler regeneration | 38.2 | 126 | Citations (PDF) |
| 64 | The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer | 8.6 | 17 | Citations (PDF) |
| 65 | CUL7 promotes cancer cell survival through promoting Caspase‐8 ubiquitination | 4.5 | 19 | Citations (PDF) |
| 66 | The role of E3 ubiquitin ligase HECTD3 in cancer and beyond | 5.6 | 22 | Citations (PDF) |
| 67 | A novel synthetic ursolic acid derivative inhibits growth and induces apoptosis in breast cancer cell lines | 1.8 | 11 | Citations (PDF) |
| 68 | Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer | 5.5 | 16 | Citations (PDF) |
| 69 | Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis | 6.6 | 109 | Citations (PDF) |
| 70 | Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1 | 3.7 | 30 | Citations (PDF) |
| 71 | RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells | 6.4 | 31 | Citations (PDF) |
| 72 | Synthesis and structure–activity relationship studies of MI-2 analogues as MALT1 inhibitors | 2.7 | 14 | Citations (PDF) |
| 73 | EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer | 2.0 | 9 | Citations (PDF) |
| 74 | miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells | 7.4 | 44 | Citations (PDF) |
| 75 | CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis | 2.0 | 15 | Citations (PDF) |
| 76 | Krüpple‐like factor 5 is essential for mammary gland development and tumorigenesis | 5.2 | 25 | Citations (PDF) |
| 77 | The roles of <scp>TNFAIP</scp>2 in cancers and infectious diseases | 4.1 | 63 | Citations (PDF) |
| 78 | HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection | 9.1 | 45 | Citations (PDF) |
| 79 | Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation | 8.0 | 111 | Citations (PDF) |
| 80 | Ursolic acid derivative FZU-03,010 inhibits STAT3 and induces cell cycle arrest and apoptosis in renal and breast cancer cells | 2.0 | 30 | Citations (PDF) |
| 81 | Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells | 3.7 | 18 | Citations (PDF) |
| 82 | YD277 Suppresses Triple-Negative Breast Cancer Partially Through Activating the Endoplasmic Reticulum Stress Pathway | 11.4 | 23 | Citations (PDF) |
| 83 | 树鼩&mdash;&mdash;作为一种新颖的非人灵长类实验疾病动物模型 | 2.7 | 54 | Citations (PDF) |
| 84 | miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5 | 2.5 | 35 | Citations (PDF) |
| 85 | Characterization and phylogenetic analysis of Krüppel-like transcription factor (KLF) gene family in tree shrews (<i>Tupaia belangeri chinensis</i>) | 1.7 | 18 | Citations (PDF) |
| 86 | Dexamethasone induces docetaxel and cisplatin resistance partially through up-regulating Krüppel-like factor 5 in triple-negative breast cancer | 1.7 | 41 | Citations (PDF) |
| 87 | Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression | 11.4 | 111 | Citations (PDF) |
| 88 | The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer | 1.6 | 28 | Citations (PDF) |
| 89 | KHF16 is a Leading Structure from <i>Cimicifuga foetida</i> that Suppresses Breast Cancer Partially by Inhibiting the NF-κB Signaling Pathway | 11.4 | 32 | Citations (PDF) |
| 90 | A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5 | 8.5 | 52 | Citations (PDF) |
| 91 | Generation and characterization of a breast carcinoma model by <scp>PyMT</scp> overexpression in mammary epithelial cells of tree shrew, an animal close to primates in evolution | 4.5 | 33 | Citations (PDF) |
| 92 | Transforming growth factor-beta increases breast cancer stem cell population partially through upregulating PMEPA1 expression | 2.0 | 27 | Citations (PDF) |
| 93 | Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5) | 1.7 | 39 | Citations (PDF) |
| 94 | Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms | 2.0 | 41 | Citations (PDF) |
| 95 | BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5 | 14.1 | 152 | Citations (PDF) |
| 96 | Hippo pathway in mammary gland development and breast cancer | 2.0 | 53 | Citations (PDF) |
| 97 | The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of <i>p27</i>Kip1 | 1.7 | 65 | Citations (PDF) |
| 98 | Cucurbitacin E Induces Cell Cycle G2/M Phase Arrest and Apoptosis in Triple Negative Breast Cancer | 2.5 | 63 | Citations (PDF) |
| 99 | Tongshu Capsule Down-Regulates the Expression of Estrogen Receptor α and Suppresses Human Breast Cancer Cell Proliferation | 2.5 | 5 | Citations (PDF) |
| 100 | PTEN/PIK3CA genes are frequently mutated in spontaneous and medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumours of tree shrews | 3.3 | 19 | Citations (PDF) |
| 101 | The HECTD3 E3 Ubiquitin Ligase Suppresses Cisplatin-Induced Apoptosis via Stabilizing MALT1 | 7.2 | 35 | Citations (PDF) |
| 102 | RNF115/BCA2 E3 Ubiquitin Ligase Promotes Breast Cancer Cell Proliferation through Targeting p21Waf1/Cip1 for Ubiquitin-Mediated Degradation | 7.2 | 29 | Citations (PDF) |
| 103 | Role of KLF5 in Hormonal Signaling and Breast Cancer Development | 0.0 | 13 | Citations (PDF) |
| 104 | E3 Ubiquitin Ligase RNF126 Promotes Cancer Cell Proliferation by Targeting the Tumor Suppressor p21 for Ubiquitin-Mediated Degradation | 0.6 | 59 | Citations (PDF) |
| 105 | Krüppel-like Factor 5 Transcription Factor Promotes Microsomal Prostaglandin E2 Synthase 1 Gene Transcription in Breast Cancer | 2.3 | 39 | Citations (PDF) |
| 106 | TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis | 2.9 | 82 | Citations (PDF) |
| 107 | The Induction of Yes-Associated Protein Expression After Arterial Injury Is Crucial for Smooth Muscle Phenotypic Modulation and Neointima Formation | 6.2 | 93 | Citations (PDF) |
| 108 | YAP Promotes Breast Cell Proliferation and Survival Partially through Stabilizing the KLF5 Transcription Factor | 3.6 | 105 | Citations (PDF) |
| 109 | The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer | 4.5 | 26 | Citations (PDF) |
| 110 | PMEPA1 promotes androgen receptor‐negative prostate cell proliferation through suppressing the Smad3/4–c‐Myc–p21$^{{\rm Cip1}}$ signaling pathway | 5.2 | 49 | Citations (PDF) |
| 111 | The Induction of KLF5 Transcription Factor by Progesterone Contributes to Progesterone-Induced Breast Cancer Cell Proliferation and Dedifferentiation | 3.6 | 49 | Citations (PDF) |
| 112 | WWP1: a versatile ubiquitin E3 ligase in signaling and diseases | 5.6 | 96 | Citations (PDF) |
| 113 | Reactive oxygen species control senescence‐associated matrix metalloproteinase‐1 through c‐Jun‐N‐terminal kinase | 4.2 | 68 | Citations (PDF) |
| 114 | The Fbw7 Tumor Suppressor Targets KLF5 for Ubiquitin-Mediated Degradation and Suppresses Breast Cell Proliferation | 0.6 | 129 | Citations (PDF) |
| 115 | Regulation of Krüpple-Like Factor 5 by Targeted Protein Degradation | 0.0 | 6 | Citations (PDF) |
| 116 | KLF5 Promotes Breast Cell Survival Partially through Fibroblast Growth Factor-binding Protein 1-pERK-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization | 2.3 | 71 | Citations (PDF) |
| 117 | Overexpression of WWP1 is associated with the estrogen receptor and insulin‐like growth factor receptor 1 in breast carcinoma | 4.5 | 41 | Citations (PDF) |
| 118 | Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases | 5.6 | 220 | Citations (PDF) |
| 119 | Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway | 2.8 | 31 | Citations (PDF) |
| 120 | The amplifiedWWP1 gene is a potential molecular target in breast cancer | 4.5 | 115 | Citations (PDF) |
| 121 | The Nedd4-like family of E3 ubiquitin ligases and cancer | 7.2 | 185 | Citations (PDF) |
| 122 | KLF5 promotes cell proliferation and tumorigenesis through gene regulationin the TSU-Pr1 human bladder cancer cell line | 4.5 | 127 | Citations (PDF) |
| 123 | Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer | 2.9 | 52 | Citations (PDF) |
| 124 | KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia | 2.3 | 97 | Citations (PDF) |
| 125 | Ubiquitin–proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells | 6.6 | 120 | Citations (PDF) |
| 126 | Human Kruppel-like Factor 5 Is a Target of the E3 Ubiquitin Ligase WWP1 for Proteolysis in Epithelial Cells | 2.3 | 120 | Citations (PDF) |
| 127 | Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells | 2.4 | 38 | Citations (PDF) |
| 128 | <i>KLF5</i> is frequently deleted and down‐regulated but rarely mutated in prostate cancer | 2.2 | 118 | Citations (PDF) |
| 129 | Deletion, Mutation, and Loss of Expression of KLF6 in Human Prostate Cancer | 3.6 | 129 | Citations (PDF) |
| 130 | A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer | 6.6 | 130 | Citations (PDF) |
| 131 | Defining a common region of deletion at 13q21 in human cancers | 3.5 | 31 | Citations (PDF) |
| 132 | Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1 | 1.6 | 6 | Citations (PDF) |
